| Analysis | Samples | Factors | Units |
|---|---|---|---|
| Reversed phase UNSPECIFIED ION MODE | 13 | Mouse_Genotype:MCAD-/- | Treatment:Cs | Peak height normalized with creatinine |
| Reversed phase UNSPECIFIED ION MODE | 14 | Mouse_Genotype:MCAD-/- | Treatment:Cs | Peak height normalized with creatinine |
| Reversed phase UNSPECIFIED ION MODE | 15 | Mouse_Genotype:MCAD-/- | Treatment:Cs | Peak height normalized with creatinine |
| Reversed phase UNSPECIFIED ION MODE | 23 | Mouse_Genotype:MCAD-/- | Treatment:Cs | Peak height normalized with creatinine |
| Reversed phase UNSPECIFIED ION MODE | 24 | Mouse_Genotype:MCAD-/- | Treatment:Cs | Peak height normalized with creatinine |
| Reversed phase UNSPECIFIED ION MODE | 33 | Mouse_Genotype:MCAD-/- | Treatment:Cs | Peak height normalized with creatinine |
| Reversed phase UNSPECIFIED ION MODE | 34 | Mouse_Genotype:MCAD-/- | Treatment:Cs | Peak height normalized with creatinine |
| Reversed phase UNSPECIFIED ION MODE | 35 | Mouse_Genotype:MCAD-/- | Treatment:Cs | Peak height normalized with creatinine |
| Reversed phase UNSPECIFIED ION MODE | 36 | Mouse_Genotype:MCAD-/- | Treatment:Cs | Peak height normalized with creatinine |
| Reversed phase UNSPECIFIED ION MODE | 37 | Mouse_Genotype:MCAD-/- | Treatment:Cs | Peak height normalized with creatinine |
| Reversed phase UNSPECIFIED ION MODE | 38 | Mouse_Genotype:MCAD-/- | Treatment:Cs | Peak height normalized with creatinine |
| Reversed phase UNSPECIFIED ION MODE | 39 | Mouse_Genotype:MCAD-/- | Treatment:Cs | Peak height normalized with creatinine |
| Reversed phase UNSPECIFIED ION MODE | 10 | Mouse_Genotype:MCAD+/+ | Treatment:Cs | Peak height normalized with creatinine |
| Reversed phase UNSPECIFIED ION MODE | 11 | Mouse_Genotype:MCAD+/+ | Treatment:Cs | Peak height normalized with creatinine |
| Reversed phase UNSPECIFIED ION MODE | 12 | Mouse_Genotype:MCAD+/+ | Treatment:Cs | Peak height normalized with creatinine |
| Reversed phase UNSPECIFIED ION MODE | 16 | Mouse_Genotype:MCAD+/+ | Treatment:Cs | Peak height normalized with creatinine |
| Reversed phase UNSPECIFIED ION MODE | 17 | Mouse_Genotype:MCAD+/+ | Treatment:Cs | Peak height normalized with creatinine |
| Reversed phase UNSPECIFIED ION MODE | 18 | Mouse_Genotype:MCAD+/+ | Treatment:Cs | Peak height normalized with creatinine |
| Reversed phase UNSPECIFIED ION MODE | 19 | Mouse_Genotype:MCAD+/+ | Treatment:Cs | Peak height normalized with creatinine |
| Reversed phase UNSPECIFIED ION MODE | 20 | Mouse_Genotype:MCAD+/+ | Treatment:Cs | Peak height normalized with creatinine |
| Reversed phase UNSPECIFIED ION MODE | 21 | Mouse_Genotype:MCAD+/+ | Treatment:Cs | Peak height normalized with creatinine |
| Reversed phase UNSPECIFIED ION MODE | 22 | Mouse_Genotype:MCAD+/+ | Treatment:Cs | Peak height normalized with creatinine |
| Reversed phase UNSPECIFIED ION MODE | 9 | Mouse_Genotype:MCAD+/+ | Treatment:Cs | Peak height normalized with creatinine |
| Reversed phase UNSPECIFIED ION MODE | 43 | Mouse_Genotype:MCAD-/- | Treatment:GF | Peak height normalized with creatinine |
| Reversed phase UNSPECIFIED ION MODE | 44 | Mouse_Genotype:MCAD-/- | Treatment:GF | Peak height normalized with creatinine |
| Reversed phase UNSPECIFIED ION MODE | 45 | Mouse_Genotype:MCAD-/- | Treatment:GF | Peak height normalized with creatinine |
| Reversed phase UNSPECIFIED ION MODE | 46 | Mouse_Genotype:MCAD-/- | Treatment:GF | Peak height normalized with creatinine |
| Reversed phase UNSPECIFIED ION MODE | 47 | Mouse_Genotype:MCAD-/- | Treatment:GF | Peak height normalized with creatinine |
| Reversed phase UNSPECIFIED ION MODE | 48 | Mouse_Genotype:MCAD-/- | Treatment:GF | Peak height normalized with creatinine |
| Reversed phase UNSPECIFIED ION MODE | 49 | Mouse_Genotype:MCAD-/- | Treatment:GF | Peak height normalized with creatinine |
| Reversed phase UNSPECIFIED ION MODE | 5 | Mouse_Genotype:MCAD-/- | Treatment:GF | Peak height normalized with creatinine |
| Reversed phase UNSPECIFIED ION MODE | 50 | Mouse_Genotype:MCAD-/- | Treatment:GF | Peak height normalized with creatinine |
| Reversed phase UNSPECIFIED ION MODE | 51 | Mouse_Genotype:MCAD-/- | Treatment:GF | Peak height normalized with creatinine |
| Reversed phase UNSPECIFIED ION MODE | 52 | Mouse_Genotype:MCAD-/- | Treatment:GF | Peak height normalized with creatinine |
| Reversed phase UNSPECIFIED ION MODE | 6 | Mouse_Genotype:MCAD-/- | Treatment:GF | Peak height normalized with creatinine |
| Reversed phase UNSPECIFIED ION MODE | 7 | Mouse_Genotype:MCAD-/- | Treatment:GF | Peak height normalized with creatinine |
| Reversed phase UNSPECIFIED ION MODE | 8 | Mouse_Genotype:MCAD-/- | Treatment:GF | Peak height normalized with creatinine |
| Reversed phase UNSPECIFIED ION MODE | 1 | Mouse_Genotype:MCAD+/+ | Treatment:GF | Peak height normalized with creatinine |
| Reversed phase UNSPECIFIED ION MODE | 2 | Mouse_Genotype:MCAD+/+ | Treatment:GF | Peak height normalized with creatinine |
| Reversed phase UNSPECIFIED ION MODE | 25 | Mouse_Genotype:MCAD+/+ | Treatment:GF | Peak height normalized with creatinine |
| Reversed phase UNSPECIFIED ION MODE | 26 | Mouse_Genotype:MCAD+/+ | Treatment:GF | Peak height normalized with creatinine |
| Reversed phase UNSPECIFIED ION MODE | 27 | Mouse_Genotype:MCAD+/+ | Treatment:GF | Peak height normalized with creatinine |
| Reversed phase UNSPECIFIED ION MODE | 28 | Mouse_Genotype:MCAD+/+ | Treatment:GF | Peak height normalized with creatinine |
| Reversed phase UNSPECIFIED ION MODE | 29 | Mouse_Genotype:MCAD+/+ | Treatment:GF | Peak height normalized with creatinine |
| Reversed phase UNSPECIFIED ION MODE | 3 | Mouse_Genotype:MCAD+/+ | Treatment:GF | Peak height normalized with creatinine |
| Reversed phase UNSPECIFIED ION MODE | 30 | Mouse_Genotype:MCAD+/+ | Treatment:GF | Peak height normalized with creatinine |
| Reversed phase UNSPECIFIED ION MODE | 31 | Mouse_Genotype:MCAD+/+ | Treatment:GF | Peak height normalized with creatinine |
| Reversed phase UNSPECIFIED ION MODE | 32 | Mouse_Genotype:MCAD+/+ | Treatment:GF | Peak height normalized with creatinine |
| Reversed phase UNSPECIFIED ION MODE | 4 | Mouse_Genotype:MCAD+/+ | Treatment:GF | Peak height normalized with creatinine |
| Reversed phase UNSPECIFIED ION MODE | 40 | Mouse_Genotype:MCAD+/+ | Treatment:GF | Peak height normalized with creatinine |
| Reversed phase UNSPECIFIED ION MODE | 41 | Mouse_Genotype:MCAD+/+ | Treatment:GF | Peak height normalized with creatinine |
Return to study ST001633 main page
Download data matrix(Aromatic amino acid metabolism by the anaerobic gut bacterium Clostridium sporogenes (part-II) Reversed phase UNSPECIFIED ION MODE)
- Metabolomics Workbench
|